Arrowhead Pharmaceuticals, Inc. (ARWR)
NMS – Real Time Price. Currency in USD
89.21
-0.03 (-0.03%)
Market open: Aug 12, 2026, 12:27 PM EDT
88.64
-0.60 (-0.67%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
89.21
-0.03 (-0.03%)
Market open: Aug 12, 2026, 12:27 PM EDT
88.64
-0.60 (-0.67%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Total debt $1.4B significantly exceeds cash reserves ($54.8M), raising financial stability concerns
Total current assets $1.7B exceed Total current liabilities $283.3M, highlighting excellent liquidity
Debt-to-equity ratio (3.0) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-6.9x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$181.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.90 | 6.05 | 10 | |
| Quick ratio | 5.90 | 5.63 | 10 | |
| Debt to Equity | 2.96 | 0.30 | 2.0 | |
| Debt to Assets | 0.65 | 1.04 | 3.0 | |
| Interest coverage | -6.92 | -16.91 | 1.0 | |
| Weighted average score | 5.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 243M | 241M | 4M | 829M | 669M |
| Gross Profit | 233M | 228M | -15M | 806M | 644M |
| Operating Income | -179M | -205M | -601M | 98M | -226M |
| Net Income | -176M | -205M | -599M | -2M | -320M |
| EBITDA | -168M | -193M | -582M | 122M | -201M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -72.02 | -1286.36 | 1.0 |
| Next quarter | -86.14 | -741.82 | 1.0 |
| Current year | -42.45 | -35033.33 | 1.0 |
| Next year | -28.2 | -34.23 | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 2.06 | -46.36 | -46.23 | -321.45 | 1.5 |
| Y/Y | 171.02 | -10.85 | -7.93 | -19.22 | 3.3 |
| 3y average | 7719.54 | -36.28 | -25.18 | -10.6 | 3.3 |
| 5y average | 4658.33 | -40.08 | -32.04 | -4.43 | 3.3 |
| Weighted average score | 2.9 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Wide | 10 |
| Intangible assets | Wide | 8.0 |
| Switching costs | Narrow | 3.0 |
| Network effect | None | 1.0 |
| Economies of scale | Narrow | 3.0 |
| Weighted average score | 5.0 | |